A prospective, multicenter study to investigate the efficacy, safety and tolerability of octreotide LAR (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly - Mercado, M; Borges, F; Bouterfa, H (Clinical Endocrinology, 2007)
et al.